Exome Asset Management’s Guardant Health GH Stock Holding History

Exome Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.64M	Sell	82,736 -15,446	-16%	-$1.55M	3.95%	6
2025 Q4	$10M	Hold	98,182	–	–	4.79%	3
2025 Q3	$6.13M	Hold	98,182	–	–	3.71%	5
2025 Q2	$5.11M	Sell	98,182 -29,000	-23%	-$1.3M	3.8%	3
2025 Q1	$5.42M	Sell	127,182 -20,618	-14%	-$890K	4.82%	2
2024 Q4	$4.52M	Buy	147,800 +58,000	+65%	+$1.63M	3.39%	5
2024 Q3	$2.06M	Buy	89,800 +10,800	+14%	+$306K	1.39%	34
2024 Q2	$2.28M	Hold	79,000	–	–	2.03%	23
2024 Q1	$1.63M	Buy	+79,000	New	+$1.69M	1.4%	32

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Exome Asset Management's GH Position: Q1 2026 in Review

Exome Asset Management reduced its Guardant Health (GH) stake by 16% in Q1 2026, selling an estimated $1.55M and leaving 82,736 shares worth $7.64M. The position accounts for 3.95% of the portfolio, ranked #6.

Exome Asset Management first reported a position in GH in Q1 2024 and has held it in 9 quarters since. The position peaked at $10M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Exome Asset Management held 82,736 shares of Guardant Health worth $7.64M as of Q1 2026.
Exome Asset Management sold 15,446 Guardant Health shares in Q1 2026, an estimated $1.55M.
Guardant Health made up 3.95% of Exome Asset Management's portfolio in Q1 2026, its #6 holding.
Exome Asset Management first reported a position in Guardant Health in Q1 2024 and has held it in 9 quarters since.
Exome Asset Management's Guardant Health position peaked at $10M in Q4 2025.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Exome Asset Management's 13F filing for Q1 2026, filed 15 May 2026.